Where is Avenio located?

Avenio is headquartered in San Ramon, United States.

Is Avenio a funded company?

Avenio is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does Avenio rank among its competitors?

Avenio ranks 836th amongst 854 active competitors, of which 56 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Verily, which secured $300M in Mar, 2026.

Who are the top competitors of Avenio?

Avenio's top competitors include Medidata, Verily and IQVIA. Among them, Verily secured the most recent funding round in March, 2026.

Avenio - 2026 Company Profile & Competitors

Company Details

Developer of an agentic AI platform for biopharma and CROs. The platform supports clinical trial protocol development and execution. It streamlines literature reviews, data collection, and amendment processes. The platform also facilitates proactive adverse drug reaction monitoring.

Key Metrics

Founded Year

2018

Location

San Ramon, United States

Stage

Unfunded

Ranked

836^th among 854 active competitors

Similar Companies

Medidata & 347 more

View Avenio's full profile

Avenio has not raised any funding rounds yet.

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Avenio include Medidata, Verily and IQVIA. Here is the list of Top 10 competitors of Avenio, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Medidata 1999, New York City (United States), Acquired	AI-based clinical trial management software for researchers	$41.5M	Insight Partners, TFS & 11 others	86/100
2nd	Verily 2015, Dallas (United States), Series D	A data platform and technology company purpose-built to power AI-enabled precision health	$2.8B	Silver Lake, Temasek & 9 others	82/100
3rd	IQVIA 1982, Durham (United States), Public	Provider of clinical research and commercialization solutions for healthcare	$1.74M	Leonard Green and Partners, Morgan Stanley ... & 12 others	80/100
4th	Tempus 2015, Chicago (United States), Public	Developer of genomic testing and artificial intelligence tools for medicine	$1.05B	New Enterprise Associates, T. Rowe Price ... & 11 others	78/100
5th	Signant Health 2000, Plymouth Meeting (United States), Acquired	Provider of a software solution for clinical trial management	$3.4M	Harvest Partners, 3i Group & 4 others	72/100
6th	Science 37 2014, Los Angeles (United States), Acquired	Provider of a suite solution for clinical trials for researchers	$106M	Redmile Group, Lux Capital & 12 others	70/100
7th	Viz.ai 2016, San Francisco (United States), Series D	Developer of an AI-powered platform for care coordination and disease detection	$252M	Insight Partners, Tiger Global Management ... & 16 others	70/100
8th	Massive Bio 2014, New York City (United States), Series B	Provider of AI-based clinical trial management tool	$15.6M	Revo Capital, Philips HealthWorks & 8 others	67/100
9th	TriNetX 2013, Cambridge (United States), Acquired	Provider of clinical trial management software for researchers and professionals	$102M	Merck Global Health Innovation Fund, MPM Capital ... & 6 others	66/100
10th	BrightInsight 2017, San Jose (United States), Series C	Provider of digital health solutions for clinical trials	$179M	Insight Partners, General Catalyst & 8 others	64/100
836th	Avenio 2018, San Ramon (United States), Unfunded	Developer of an agentic AI platform for biopharma and CROs	-	-	16/100